Biotech

cardiovascular disease
Biotech

Novo calls off $598M Heartseed collab, citing 'strategic reviews'

Japanese biotech Heartseed said it was "difficult to reasonably foresee" that Novo would scrap the 2021 deal, despite the pharma's restructuring.
Zoey Becker Sep 30, 2025 1:55pm
workers

Fierce Biotech Layoff Tracker 2025: Heidelberg, IO & more

Sep 30, 2025 11:00am
Carl Sailer on AI market trends and strategic planning in biotech

Carl Sailer on AI, market trends, and strategic planning in biotech

Oct 28, 2024 8:00pm
Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Barinthus enters reverse merger with metabolic disease biotech

Sep 30, 2025 10:39am
Guidehouses Karla Anderson shares top tips for successful biotech commercialization

Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization

Oct 28, 2024 8:00am
direction arrow

Anaptys plans to split into 2 businesses

Sep 30, 2025 9:35am